Literature DB >> 26830296

[CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases. German version].

T Tsubata1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26830296     DOI： 10.1007/s00393-015-0038-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  24 in total

1.  CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.

Authors:  Julia Jellusova; Ute Wellmann; Kerstin Amann; Thomas H Winkler; Lars Nitschke
Journal:  J Immunol       Date:  2010-03-03       Impact factor: 5.422

Review 2.  Siglec-mediated regulation of immune cell function in disease.

Authors:  Matthew S Macauley; Paul R Crocker; James C Paulson
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

Review 3.  FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus.

Authors:  Heather A Niederer; Menna R Clatworthy; Lisa C Willcocks; Kenneth G C Smith
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling.

Authors:  Jennifer Müller; Ingrid Obermeier; Miriam Wöhner; Carolin Brandl; Sarah Mrotzek; Sieglinde Angermüller; Palash C Maity; Michael Reth; Lars Nitschke
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-08       Impact factor: 11.205

5.  The B-cell surface protein CD72/Lyb-2 is the ligand for CD5.

Authors:  H Van de Velde; I von Hoegen; W Luo; J R Parnes; K Thielemans
Journal:  Nature       Date:  1991-06-20       Impact factor: 49.962

6.  Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.

Authors:  Miduo Xu; Rong Hou; Aya Sato-Hayashizaki; Rongyong Man; Chenghua Zhu; Chisato Wakabayashi; Sachiko Hirose; Takahiro Adachi; Takeshi Tsubata
Journal:  J Immunol       Date:  2013-04-24       Impact factor: 5.422

7.  Modulation of peripheral B cell tolerance by CD72 in a murine model.

Authors:  Daniel Hsieh-Hsin Li; Monte M Winslow; Thai M Cao; Albert H Chen; Corrine R Davis; Elizabeth D Mellins; Paul J Utz; Gerald R Crabtree; Jane R Parnes
Journal:  Arthritis Rheum       Date:  2008-10

8.  CD72 polymorphisms associated with alternative splicing modify susceptibility to human systemic lupus erythematosus through epistatic interaction with FCGR2B.

Authors:  Yuki Hitomi; Naoyuki Tsuchiya; Aya Kawasaki; Jun Ohashi; Takeshi Suzuki; Chieko Kyogoku; Toru Fukazawa; Sasitorn Bejrachandra; Usanee Siriboonrit; Dasnayanee Chandanayingyong; Puan Suthipinittharm; Betty P Tsao; Hiroshi Hashimoto; Zen-ichiro Honda; Katsushi Tokunaga
Journal:  Hum Mol Genet       Date:  2004-09-30       Impact factor: 6.150

9.  Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.

Authors:  Aaron F Carlin; Satoshi Uchiyama; Yung-Chi Chang; Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113

10.  Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling.

Authors:  Lei Jin; Paul A McLean; Benjamin G Neel; Henry H Wortis
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.